A031803

Phase II Trial of Intravesical Gemcitabine and MK-3475 (pembrolizumab) in the Treatment of Patients with BCG-Unresponseve Non-Muscle Invasive Bladder Cancer
Contact phone
Clinical Trials Office 517-364-9400
Principal investigator
Gordan Srkalovic, MD, PhD
Trial Category
Cancer
Trial SubCategory
Bladder